Mahsa Mohammadi Lapevandani, Elham Bazmi, Shima Jahani, Nasrin Asgari, Mohammad Ali Sahraian
{"title":"神经脊髓炎视谱障碍的环境危险因素:系统综述。","authors":"Mahsa Mohammadi Lapevandani, Elham Bazmi, Shima Jahani, Nasrin Asgari, Mohammad Ali Sahraian","doi":"10.1177/17562864251363293","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neuromyelitis optica spectrum disorder (NMOSD) may be triggered by environmental risk factors.</p><p><strong>Objectives: </strong>We aimed to explore and integrate the recent research advances in this field. Here we describe relevant studies and summarize current knowledge on non-genetic factors that influence the onset of the disease.</p><p><strong>Design: </strong>Systematic review.</p><p><strong>Methods: </strong>We performed a systematic review up to May 21, 2024, following preferred reporting items for systematic reviews and meta-analyses guidelines. Two independent reviewers evaluated the quality of the included studies using the Joanna Briggs Institute checklist for risk of bias assessment.</p><p><strong>Data sources: </strong>MEDLINE, EMBASE, Scopus, and Web of Science databases.</p><p><strong>Results: </strong>A total of 15,869 articles were evaluated. Of those 50 studies met the eligibility criteria. A total of 21,410 NMOSD patients were included in the studies; 17,080 patients were females. Totally, 14 risk factors, including vitamin D deficiency, vaccination, virus infections, lifestyle, and dietary factors, were assessed. A total of 37% of the included articles were conducted in East Asia, mainly focusing on the effects of infection and vitamin D deficiency. These studies suggested vitamin D deficiency as a possible NMOSD risk factor. A total of 25% of the studies included Caucasian populations from Western countries. They showed that smoking decreased the odds of NMOSD, in contrast to observations from Eastern studies. Few cases reported NMOSD onset after COVID-19 vaccination. Antibodies against Epstein-Barr virus, <i>Mycobacterium paratuberculosis</i>, and <i>Helicobacter pylori</i> were observed to be more frequently positive in the serum of NMOSD patients. Lower protein and fat and higher carbohydrate intakes were correlated with NMOSD development.</p><p><strong>Conclusion: </strong>Vitamin D deficiency, cigarette smoking, <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> infection, and diet were reported as environmental risk factors for NMOSD. The difference in the onset of NMOSD between Asian and Caucasian populations could be affected by smoking and vitamin D deficiency. Knowledge of modifiable risk factors for NMOSD may be beneficial in preventing and improving disease outcomes.</p>","PeriodicalId":22980,"journal":{"name":"Therapeutic Advances in Neurological Disorders","volume":"18 ","pages":"17562864251363293"},"PeriodicalIF":4.1000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511702/pdf/","citationCount":"0","resultStr":"{\"title\":\"Environmental risk factors of neuromyelitis optica spectrum disorder: a systematic review.\",\"authors\":\"Mahsa Mohammadi Lapevandani, Elham Bazmi, Shima Jahani, Nasrin Asgari, Mohammad Ali Sahraian\",\"doi\":\"10.1177/17562864251363293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Neuromyelitis optica spectrum disorder (NMOSD) may be triggered by environmental risk factors.</p><p><strong>Objectives: </strong>We aimed to explore and integrate the recent research advances in this field. Here we describe relevant studies and summarize current knowledge on non-genetic factors that influence the onset of the disease.</p><p><strong>Design: </strong>Systematic review.</p><p><strong>Methods: </strong>We performed a systematic review up to May 21, 2024, following preferred reporting items for systematic reviews and meta-analyses guidelines. Two independent reviewers evaluated the quality of the included studies using the Joanna Briggs Institute checklist for risk of bias assessment.</p><p><strong>Data sources: </strong>MEDLINE, EMBASE, Scopus, and Web of Science databases.</p><p><strong>Results: </strong>A total of 15,869 articles were evaluated. Of those 50 studies met the eligibility criteria. A total of 21,410 NMOSD patients were included in the studies; 17,080 patients were females. Totally, 14 risk factors, including vitamin D deficiency, vaccination, virus infections, lifestyle, and dietary factors, were assessed. A total of 37% of the included articles were conducted in East Asia, mainly focusing on the effects of infection and vitamin D deficiency. These studies suggested vitamin D deficiency as a possible NMOSD risk factor. A total of 25% of the studies included Caucasian populations from Western countries. They showed that smoking decreased the odds of NMOSD, in contrast to observations from Eastern studies. Few cases reported NMOSD onset after COVID-19 vaccination. Antibodies against Epstein-Barr virus, <i>Mycobacterium paratuberculosis</i>, and <i>Helicobacter pylori</i> were observed to be more frequently positive in the serum of NMOSD patients. Lower protein and fat and higher carbohydrate intakes were correlated with NMOSD development.</p><p><strong>Conclusion: </strong>Vitamin D deficiency, cigarette smoking, <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> infection, and diet were reported as environmental risk factors for NMOSD. The difference in the onset of NMOSD between Asian and Caucasian populations could be affected by smoking and vitamin D deficiency. Knowledge of modifiable risk factors for NMOSD may be beneficial in preventing and improving disease outcomes.</p>\",\"PeriodicalId\":22980,\"journal\":{\"name\":\"Therapeutic Advances in Neurological Disorders\",\"volume\":\"18 \",\"pages\":\"17562864251363293\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511702/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Neurological Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17562864251363293\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Neurological Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562864251363293","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:神经脊髓炎视谱障碍(NMOSD)可能由环境危险因素引发。目的:探讨和整合该领域的最新研究进展。在这里,我们描述了相关研究,并总结了目前对影响疾病发病的非遗传因素的认识。设计:系统回顾。方法:我们进行了一项截至2024年5月21日的系统评价,遵循系统评价和荟萃分析指南的首选报告项目。两名独立审稿人使用乔安娜布里格斯研究所的偏倚风险评估清单评估纳入研究的质量。数据来源:MEDLINE, EMBASE, Scopus和Web of Science数据库。结果:共评估15869篇文献。这50项研究中有50项符合资格标准。共有21410名NMOSD患者纳入研究;女性17,080例。总共评估了14个危险因素,包括维生素D缺乏、疫苗接种、病毒感染、生活方式和饮食因素。所纳入的文章中有37%是在东亚进行的,主要关注感染和维生素D缺乏的影响。这些研究表明维生素D缺乏可能是NMOSD的危险因素。总共25%的研究包括来自西方国家的高加索人群。他们表明,与东方研究的观察结果相反,吸烟降低了NMOSD的几率。少数病例报告在COVID-19疫苗接种后发生NMOSD。NMOSD患者血清中Epstein-Barr病毒抗体、副结核分枝杆菌抗体和幽门螺杆菌抗体阳性更为常见。较低的蛋白质和脂肪以及较高的碳水化合物摄入量与NMOSD的发展相关。结论:维生素D缺乏、吸烟、鸟分枝杆菌亚种副结核感染和饮食是NMOSD的环境危险因素。亚洲和高加索人群NMOSD发病的差异可能受到吸烟和维生素D缺乏的影响。了解NMOSD可改变的危险因素可能有助于预防和改善疾病结果。
Environmental risk factors of neuromyelitis optica spectrum disorder: a systematic review.
Background: Neuromyelitis optica spectrum disorder (NMOSD) may be triggered by environmental risk factors.
Objectives: We aimed to explore and integrate the recent research advances in this field. Here we describe relevant studies and summarize current knowledge on non-genetic factors that influence the onset of the disease.
Design: Systematic review.
Methods: We performed a systematic review up to May 21, 2024, following preferred reporting items for systematic reviews and meta-analyses guidelines. Two independent reviewers evaluated the quality of the included studies using the Joanna Briggs Institute checklist for risk of bias assessment.
Data sources: MEDLINE, EMBASE, Scopus, and Web of Science databases.
Results: A total of 15,869 articles were evaluated. Of those 50 studies met the eligibility criteria. A total of 21,410 NMOSD patients were included in the studies; 17,080 patients were females. Totally, 14 risk factors, including vitamin D deficiency, vaccination, virus infections, lifestyle, and dietary factors, were assessed. A total of 37% of the included articles were conducted in East Asia, mainly focusing on the effects of infection and vitamin D deficiency. These studies suggested vitamin D deficiency as a possible NMOSD risk factor. A total of 25% of the studies included Caucasian populations from Western countries. They showed that smoking decreased the odds of NMOSD, in contrast to observations from Eastern studies. Few cases reported NMOSD onset after COVID-19 vaccination. Antibodies against Epstein-Barr virus, Mycobacterium paratuberculosis, and Helicobacter pylori were observed to be more frequently positive in the serum of NMOSD patients. Lower protein and fat and higher carbohydrate intakes were correlated with NMOSD development.
Conclusion: Vitamin D deficiency, cigarette smoking, Mycobacterium avium subspecies paratuberculosis infection, and diet were reported as environmental risk factors for NMOSD. The difference in the onset of NMOSD between Asian and Caucasian populations could be affected by smoking and vitamin D deficiency. Knowledge of modifiable risk factors for NMOSD may be beneficial in preventing and improving disease outcomes.
期刊介绍:
Therapeutic Advances in Neurological Disorders is a peer-reviewed, open access journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of neurology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in neurology, providing a forum in print and online for publishing the highest quality articles in this area.